67,213 Shares in Colgate-Palmolive Company $CL Purchased by Providence Capital Advisors LLC

Providence Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive Company (NYSE:CLFree Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 67,213 shares of the company’s stock, valued at approximately $5,373,000.

Several other hedge funds and other institutional investors also recently modified their holdings of CL. Westside Investment Management Inc. lifted its stake in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares during the period. Vermillion & White Wealth Management Group LLC lifted its position in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares during the period. Copia Wealth Management purchased a new stake in Colgate-Palmolive in the 3rd quarter valued at approximately $29,000. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth approximately $30,000. Finally, MTM Investment Management LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $39,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

NYSE CL opened at $94.18 on Tuesday. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The business has a fifty day moving average of $82.41 and a 200-day moving average of $81.59. The stock has a market cap of $75.92 billion, a price-to-earnings ratio of 35.95, a price-to-earnings-growth ratio of 4.26 and a beta of 0.29.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter last year, the business posted $0.91 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.41% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CL. The Goldman Sachs Group reaffirmed a “buy” rating and set a $94.00 price objective on shares of Colgate-Palmolive in a report on Saturday, January 31st. Evercore upped their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, February 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research report on Tuesday, December 9th. Finally, Jefferies Financial Group lifted their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $94.47.

Check Out Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.